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Glutathione 5-Transferase and /V-Acetyltransferase Genotypes and Asbestos-Associated Pulmonary Disorders
Ari Hirvonen, Sirkku T. Saarikaski, Kaija Linnainmaa, Kari Koskinen, Kirsti Husgafvel-Pursiainen, Karin Mattson, Harri Vainio* Background: Humans vary in their ability to metabolize endogenous and exogenous compounds. Glutathione Stransferases (GSTs) and N-acetyltransferases (NATs) are enzymes involved in the detoxification of hazardous agents. The GSTM1 and GSTT1 genes exhibit null (i.e., deletion) polymorphisms; in specific individuals, homozygous deletion (i.e., both copies lost) of these genes can be detected. Polymorphism of the NAT2 gene results in slow and fast acetylators of potentially toxic substances. The GSTMl-null and the NAT2 slow-acetylator genotypes have been associated with increased risks for the development of environmentally induced cancers. Purpose: We assessed whether homozygous GSTMl-null or GSTTl-null genotypes or the NAT2 slow-acetylator genotype were associated with increased risks for the development of malignant and nonmalignant asbestos-related pulmonary disorders in a cohort of Finnish construction workers. Methods: The study population consisted of 145 asbestos insulators who were classified as having been exposed to high levels of asbestos; 69 of these individuals had no pulmonary disorders (control subjects), and 76 had either malignant mesothelioma (n = 24) or nonmalignant pulmonary disorders, such as asbestosis and/or pleural plaques (n = 52). Lymphocyte DNA and the polymerase chain reaction were used to determine the GSTM1, GSTT1, and NAT2 genotypes of the study subjects. Odds ratios (ORs) and 95% confidence intervals (CIs) estimating the relative risks of disease associated with specific genotypes were calculated from 2x2 tables by use of Fisher's exact method. Results: Risks for the development of asbestos-related pulmonary disorders were not affected significantly by homozygous deletion of the GSTM1 or GSTT1 genes. However, the risk of developing both malignant and nonmalignant pulmonary disorders for individuals with a NAT2 slow-acetylator genotype was more than twice that observed for those with a NAT2 fastacetylator genotype (OR = 2.3; 95% CI = 1.1-4.7); the risk of developing malignant mesothelioma for NAT2 slow acetylators was increased almost fourfold (OR = 3.8; 95% CI = 1. See "Notes" section following "References." malignant mesothelioma of the pleura and peritoneum, and several other pleura! diseases such as pleural plaques (7) . Since the causal relationship between asbestos exposure and pulmonary diseases was established, much work has been undertaken to understand the mechanisms of fiber-induced pathogenesis. According to present knowledge, both direct and indirect cellular effects of fibers may contribute to disease outcome. These effects include the generation of reactive free radicals, which result from interactions of fibers and target cells or are generated following the phagocytosis of fibers by inflammatory cells (2) . The other factors (e.g., individual susceptibility) that could contribute to the development of asbestos-related diseases have not yet been identified. Humans vary in their ability to metabolize exogenous and endogenous compounds, and individuals with a genetically determined reduced capacity to detoxify hazardous compounds may be at increased risk of adverse health effects compared with those with unaltered metabolic capacity (3) . In this respect, conjugation of electrophilic compounds to glutathione, mediated by glutathione Stransferases (GSTs), may be of great importance (4). The GST Ml and Tl genes are polymorphic in humans, and a phenotypic absence of enzyme activity results from the homozygous deletion of the respective genes (i.e., the null genotypes) (5, 6) . About 50% of Caucasians have the GSTMl-null genotype, which has been suggested in several studies to pose an increased risk for the development of environmentally induced cancers. To date, there are no studies on the association between the GSTTl-null genotype, which putatively has a frequency of 10%-25% in Caucasians, and individual cancer risk. However, lack of the GSTT1 gene was recently associated with an enhanced susceptibility to myelodysplastic syndromes, which are clonal proliferative disorders of bone marrow that often progress to acute myeloid leukemia (77). In addition to glutathione conjugation, acetylation by N-acetyltransferase 2 (NAT2) is an important detoxification pathway in humans (J). Consequently, the slow-acetylation-associated NAT2 genotypes, which have a frequency of about 50% among Caucasians, have been suggested to modulate individual risk for the development of, for example, environmentally induced bladder and colon cancers (5) .
We previously found an association between the occurrence of malignant mesothelioma and GSTM1 and NAT2 genotypes among workers who were highly exposed to asbestos (70). However, only a population-based control group without occupational exposure data was available, and mesothelioma was the sole asbestos-related pulmonary disorder studied. We therefore substituted the population-based control subjects with a carefully characterized group of workers who had a history of high asbestos exposure but no pulmonary disorders, and we extended the study to cover workers with two other asbestos-caused disorders, asbestosis and pleural plaques. We also assessed the recently described GSTT1 gene polymorphism (<5) to clarify further the potential role of GST genes in asbestos-associated pulmonary disorders.
Subjects and Methods

Study Subjects
The study subjects were selected from a cohort of approximately 1500 construction workers who were recruited for a health-screening survey carried out at the Finnish Institute of Occupational Health. All of the workers were interviewed for detailed occupational and smoking histories by a physician who was specialized in occupational medicine. The degree of asbestos exposure, on the basis of all available data (e.g., personal interview and measurements of lung fiber burden from some of the patients with mesothelioma), was classified as 1) definite or probable, 2) possible, and 3) unlikely/unknown. On the basis of the data, individuals were classified to high, moderate, or low asbestos-exposure groups. A subcohort of asbestos insulators who were classified to the high asbestos-exposure group comprised the present study population consisting of 145 workers, 69 of whom had no pulmonary disorders detectable in thorax x rays (mean subject age, 52.8 years [standard deviation, 9.0 years]) and 76 of whom had developed either malignant mesothelioma (n = 24) or nonmalignant pulmonary disorders (asbestosis and/or pleural plaques) (n = 52) (mean subject age, 55.7 years [standard deviation, 9.3 years]). The distribution of years of known asbestos exposure was as follows: 1-9 years (n = 29); 10-19 years (n = 17); 20-29 years (n = 54); and 30 years or more (n = 45). A minority of the study subjects were never smokers, both among the healthy workers (25 of 76 [33%]) and among the workers with pulmonary disorders (16 
Determination of Genetic Polymorphisms
Genomic DNA was extracted from lymphocytes by the use of standard techniques. A multiplex polymerase chain reaction (PCR) method was used to detect the presence or absence of the GSTM1 and GSTT1 genes as described by Chen et al. (//) . This modified PCR method (5,6,9,12) had both GSTspecific pnmer pairs in the same amplification mixture and included a third primer pair for f5-globin. The PCR mixture was composed of 100 ng genomic DNA template, 30 pmol of each GST primer (G5-5'GAA CTC CCT GAA AAG CTA AAG C3' and G6-5'GTT GGG CTC AAA TAT ACG GTG G3', for amplifying GSTM1; gsttF-5TTC CTT ACT GGT CCT CAC ATC TC3' and gsttR-5TCA CCG GAT CAT GGC CAG CA3', for amplifying , and 80 (ig/mL bovine serum albumin). The reaction mixture was assembled at 85 "C, placed in a PerkinElmer 9600 thermal cycler (Perkin-Elmer Cetus, Norwalk, CT) for 3 minutes at 94 "C, and then subjected to 30 cycles of 94 "C for 10 seconds, 60 'C for 20 seconds, and 72 'C for 45 seconds. The thermal cycling program was followed by a final step at 72 "C for 5 minutes. The GSTT1 (480 base pair [bp]), P-globin (268 bp), and GSTM1 (215 bp) amplification products were resolved in an ethidium bromide-stained 4% 3:1 NuSieve/agarose gel (FMC Corp., Rockland, ME). The absence of the GSTM1- *OR = odds ratio; CI = confidence interval; null = absence of the gene; slow = slow acetylator. tMalignant mesothelioma.
or the GSTT1-specific fragment indicated the corresponding null genotype, whereas the p^-globinspecific fragment confirmed the presence of amplifiable DNA in die reaction mixture (//). To verify the GSTTl-null genotype further and to ensure that DNA degradation did not influence the results, a second PCR was performed that yielded a 112-bp fragment (data not shown). The NAT2 allele corresponding to the fastacetylator phenotype and the four slow-acetylator phenotype-associated alleles were distinguished by use of pnmers specific for the NAT2 gene in a PCR reaction and restriction enzyme digestion of the resulting amplification product as described by Bell et al. (13) . A single PCR was earned out using 50 pmol of the primers (N5-5'GGA ACA AAT TGG ACT TGG3' and N4-5TCT AGC ATG AAT CAC TCT GC3' [synthesized by Institute of Biotechnology]), 200 umol dNTPs (Boehringer Mannheim GmbH), 1 U Taq polymerase (Promega Corp.), and 2.0 nW MgCl 2 (Promega Corp.) in a volume of 50 uL with the above-described PCR buffer. After PCR, which was performed as indicated for the GST analyses, except that an annealing temperature of 57 'C was used, 7.5-|iL aliquots were removed and subjected to restriction digestion with Kpn I (for the M1 allele), Taq I (for the M2 allele), BamHl (for the M3 allele), or Msp UAlu I (for the M4 allele). (The restriction enzymes were from New England Biolabs, Inc., Beverly, MA.) The digests were subjected to electrophoresis in 4% agarose gels. The absence of a restriction site indicated the presence of a defective NAT2 allele, and the presence of two defective alleles identified the slow acetylators (13) 
Statistical Methods
The odds ratio (OR) is an estimate of the relative risk of disease associated with specific genotypes and is defined as the odds of a case patient having the at-risk genotype divided by the odds of a control subject having the same genotype. ORs and 95% confidence intervals (CIs) were calculated from 2x2 tables with the Fisher's exact model, and Pearson coefficients of correlation were calculated between determinants and potential confounders (14) .
Results and Discussion
When the three genes were studied separately (Table 1) , no statistically significant differences were observed for the GST genotypes, although the frequency of the GSTM 1-null genotype was clearly higher among the patients with malignant mesothelioma (67%) and somewhat higher among the asbestos workers with nonmalignant pulmonary disorders (58%) than among workers who lacked evidence of these disorders (46%). In contrast, the NAT2 slow-acetylator genotypes were significantly more prevalent among the workers with pulmonary disorders (69%) than among those lacking them (50%) (OR = 2.3; 95% CI = 1.1-4.7). The frequency of NAT2 slow-acetylator genotypes was highest among the patients with malignant mesothelioma (79%) (OR = 3.8; 95% CI = 1.2-14.3). Moreover, the slow acetylators lacking the GSTM 1 gene had nearly an eightfold higher risk of mesothelioma (OR = 7.8; 95% CI = 1.4-78.7) compared with those who had the gene and the NAT2 fast-acetylator genotype ( Table 2 ). They were also at a fourfold higher risk of nonmalignant pulmonary disorders (OR = 4.1; 95% CI = 1.1-17.2) and, consequently, at about a fivefold higher risk overall (OR = 5.1; 95% CI = 1.6-17.6) of developing one of the pulmonary disorders studied. As expected, correlations between the genotypes and age, pack-years of cigarette smoking, duration of smoking, and duration of asbestos exposure were negligible, with correlation coefficients ranging from -0.05 to 0.12. Therefore, no adjustment of the ORs by these factors was needed. In contrast to the effects shown by combinations of GSTM1 and NAT2 genotypes, other combinations of the studied genotypes showed no additive effects. •Null = absence of the gene; positive = presence of the gene. tOR = odds ratio. OR shown is for the NAT2 slow-acetylator and GSTM 1 -null genotype combination compared with the NAT2 fast-acetylator and GSTM 1 -positive genotype combination; reference group consists of subjects with no pulmonary disorders. pZl = confidence interval. §Malignant mesothelioma.
The lack of effect of smoking in this study stands in contrast to previous analyses of the GSTM1 gene and cancer susceptibility, where the risk associated with the GSTM 1-null genotype was mostly attributable to smoking (7) (8) (9) . In the previous analyses, the associations appeared, however, to be heavily influenced by the asbestos exposure levels, in agreement with two more recent studies. An association was reported between the GSTM 1-null genotype and the risk of developing asbestosis among highly exposed asbestos workers (15) , whereas no association was found between radiographic or lung function changes and GSTM1 genotype in a group of asbestos workers with mostly low or moderate exposure levels (16) .
Certain GST isoenzymes are considered to be part of a system required for the repair of free-radical-induced lipid peroxidation (4), which is considered to be one possible mechanism in the multistep process of asbestos carcinogenesis (2) . Therefore, the observed association between the GSTM 1-null genotype and asbestos-associated pulmonary disorders was not surprising, whereas the remarkable impact of the NAT2 genotype observed both in this study and in our previous study (10) was rather unexpected. However, asbestos fibers are able to induce ornithine decarboxylase enzyme activity, resulting in increased cell proliferation as a consequence of enhanced polyamine synthesis (17) . Since an acetylation step is known to be involved in the catabolism of polyamines (18) , the slow NAT2 acetylators may accumulate greater amounts of polyamines than the fast acetylators. This could explain, in part, the modulating effect of NAT2 polymorphism in individual responses to asbestos exposure.
In conclusion, we found that, among workers with high levels of asbestos exposure, individuals concurrently having a NAT2 slow-acetylator genotype and homozygous deletion of the GSTM 1 gene showed a marked excess of asbestos-associated pulmonary disorders. Even if the present study size is relatively small, the high prevalence of these potential at-risk genotypes indicates that our observations may have important implications for public health.
